STAAR-2 Clinical Study
NCT00368901
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
618
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Chronic Renal Insufficiency
Kidney Disease
Pre-dialysis
Pre-ESRD
Interventions
DRUG:
Darbepoetin alfa
Sponsor
Amgen